Facing fire over opioid crisis, US drugmakers eye a booming new pain market in India
As India loosens its stringent narcotics laws, US companies including Johnson & Johnson, Abbott Laboratories and a network affiliated with Purdue Pharma are rushing in.
Post a Comment